abstract |
An inhalable formulation comprising SAE-CD and a corticosteroid is provided. The formulation is adapted for spray administration to a subject by means of a known nebulizer. The formulation can be included in a kit. The formulation is administered as an aqueous solution. However, it can be stored as a dry powder, a ready-to-use solution, or a concentrated composition. The formulation is used in an improved nebulization system for inhalation administration of corticosteroids. SAE-CD present in the formulation significantly increases the chemical stability of budesonide. A method of administering a formulation by inhalation is provided. The formulation can also be administered by conventional nasal delivery devices. [Selection] Figure 8 |